We live product development – transforming ground-breaking ideas into life-saving medication.


Press release on June 23, 2020

Hope for the elderly in the corona pandemic – First participants receive VPM1002 in a late-stage phase III clinical trial in Germany. Read more!

Press release on May 26, 2020

SARS-CoV-2 study kicks off in Germany:
First participant enrolled in Phase III clinical trial of VPM1002 focused on healthcare workers battling the COVID-19 pandemic. Read more!

Press release on March 20, 2020

Immune boost against the corona virus:
In Germany, a vaccine candidate will be tested for its effectiveness against infections with the novel corona virus. Read more!

Press release on March 2, 2020

VPM: First volunteer enrolled in Phase II/III Study of SIIPL Tdap vaccine in Comparison with Boostrix® in Healthy Participants. Please klick here for the press release!

Press release on February 20, 2020

Modified tuberculosis vaccine as a therapy for cancer of the bladder. A therapy with VPM1002 is effective for bladder cancer patients. Please klick here for the whole release!

Press release on the 12th International VPM Days 2019

On 12 and 13 September, the 12th International VPM Days took place at TWINCORE in Hannover. More than 20 international speakers and almost 100 visitors accepted the invitation of Vakzine Projekt Management GmbH (VPM). Read more!

powered by webEdition CMS